← All Sponsors

SPONSOR

EvolveImmune United, Inc

Total Trials

1

Recruiting

1

Phases

Phase 1

Conditions studied: Bladder Cancer Squamous Cell Carcinoma of the Lung Esophageal Squamous Cell Carcinoma Tongue Squamous Cell Carcinoma Cutaneous Squamous Cell Cancer Penile Squamous Cell Carcinoma Anal Squamous Cell Carcinoma Vulvar Squamous Cell Carcinoma Cervical Squamous Cell Carcinoma Vaginal Squamous Cell Carcinoma

NCT07217171 Phase 1

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas